BofA Securities analyst Alec Stranahan maintains $Perspective Therapeutics (CATX.US)$ with a hold rating, and maintains the target price at $6.
According to TipRanks data, the analyst has a success rate of 51.2% and a total average return of -2.7% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Perspective Therapeutics (CATX.US)$'s main analysts recently are as follows:
Perspective Therapeutics recently presented data for VMT-alpha-NET, which did not meet the expected overall response rate (ORR) when compared to industry benchmarks. There remains an opportunity for Perspective to achieve improved responses with higher dosage levels, though further data is not anticipated until late-2025 pending regulatory advancements. Additionally, initial findings for VMT01 in melanoma indicated kidney accumulation issues that could restrict dose escalation, potentially impacting the stock until further combination studies provide additional data.
Initial data from Cohort 1 and Cohort 2 of VMT-a-NET's phase I/IIa study indicate encouraging signals but underscore the need for patience in dose optimization. There appears to be a path to potential commercialization from Perspective's leading specific chelator across its pipeline and platform.
Yesterday's selloff in Perspective Therapeutics was seen as an overreaction to the early data from the dose escalation phase of the VMT-alpha-NET program, which showed clinical activity correlating with dose intensity and a clear safety profile that supports further dose escalation. This situation presents a buying opportunity, particularly with Perspective trading near cash levels.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
